Literature DB >> 21272002

The tyrosine phosphatase Shp-2 interacts with the dopamine D(1) receptor and triggers D(1) -mediated Erk signaling in striatal neurons.

Chiara Fiorentini1, Cinzia Mattanza, Ginetta Collo, Paola Savoia, Pierfranco Spano, Cristina Missale.   

Abstract

We report a novel mechanism for dopamine D(1) receptor (D(1) R)-mediated extracellular signal-regulated kinases (Erk) activation in rat striatum. Erk signaling depends on phosphorylation and dephosphorylation events mediated by specific kinases and phosphatases. The tyrosine phosphatase Shp-2, that is required for Erk activation by tyrosine kinase receptors, has been recently shown to regulate signaling downstream of few G protein-coupled receptors. We show that the D(1) R interacts with Shp-2, that D(1) R stimulation results in Shp-2 tyrosine phosphorylation and activation in primary striatal neuronal cultures and that D(1) R/Shp-2 interaction is required for transmitting D(1) R-dependent signaling to Erk1/2 activation. D(1) R-mediated Erk1/2 phosphorylation in cultured striatal neurons is in fact abolished by over-expression of the inactive Shp-2(C/S) mutant and by small interfering RNA-induced Shp-2 silencing. Moreover, by using selective inhibitors we show that both D(1) R-induced Shp-2 activation and Erk1/2 phosphorylation are dependent on the cyclic AMP/protein kinase A pathway and require Src. These results, which were substantiated also in transfected human embryonic kidney 293 cells, provide a novel mechanism by which to converge D(1) R signaling to the Erk pathway and suggest that Shp-2 or the D(1) R/Shp-2 interface could represent a potential drug target for disorders of dopamine transmission involving malfunctioning of D(1) R signaling.
© 2011 The Authors. Journal of Neurochemistry © 2011 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21272002     DOI: 10.1111/j.1471-4159.2011.07196.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  11 in total

Review 1.  Dopamine receptors - IUPHAR Review 13.

Authors:  Jean-Martin Beaulieu; Stefano Espinoza; Raul R Gainetdinov
Journal:  Br J Pharmacol       Date:  2015-01       Impact factor: 8.739

2.  Novel role for SHP-2 in nutrient-responsive control of S6 kinase 1 signaling.

Authors:  Fatih Mercan; Hojin Lee; Sivanagarani Kolli; Anton M Bennett
Journal:  Mol Cell Biol       Date:  2012-11-05       Impact factor: 4.272

3.  Loss of dopamine D1 receptors and diminished D1/5 receptor-mediated ERK phosphorylation in the periaqueductal gray after spinal cord lesion.

Authors:  Pamela J Voulalas; Yadong Ji; Li Jiang; Jamila Asgar; Jin Y Ro; Radi Masri
Journal:  Neuroscience       Date:  2016-12-05       Impact factor: 3.590

Review 4.  Dopamine receptors: homomeric and heteromeric complexes in L-DOPA-induced dyskinesia.

Authors:  Oscar Solís; Rosario Moratalla
Journal:  J Neural Transm (Vienna)       Date:  2018-02-07       Impact factor: 3.575

5.  Differential involvement of Ras-GRF1 and Ras-GRF2 in L-DOPA-induced dyskinesia.

Authors:  Simone Bido; Nicola Solari; Marzia Indrigo; Angela D'Antoni; Riccardo Brambilla; Michele Morari; Stefania Fasano
Journal:  Ann Clin Transl Neurol       Date:  2015-04-24       Impact factor: 4.511

6.  Dopamine increases CD14+CD16+ monocyte migration and adhesion in the context of substance abuse and HIV neuropathogenesis.

Authors:  Jacqueline S Coley; Tina M Calderon; Peter J Gaskill; Eliseo A Eugenin; Joan W Berman
Journal:  PLoS One       Date:  2015-02-03       Impact factor: 3.240

7.  Levodopa/Benserazide Loaded Microspheres Alleviate L-dopa Induced Dyskinesia through Preventing the Over-Expression of D1R/Shp-2/ERK1/2 Signaling Pathway in a Rat Model of Parkinson's Disease.

Authors:  Ying Wan; Na Wu; Lu Song; Xijin Wang; Zhenguo Liu; Weien Yuan; Jing Gan
Journal:  Front Aging Neurosci       Date:  2017-10-18       Impact factor: 5.750

8.  Segregation and crosstalk of D1 receptor-mediated activation of ERK in striatal medium spiny neurons upon acute administration of psychostimulants.

Authors:  Omar Gutierrez-Arenas; Olivia Eriksson; Jeanette Hellgren Kotaleski
Journal:  PLoS Comput Biol       Date:  2014-01-30       Impact factor: 4.475

9.  The abnormal activation of D1R/Shp-2 complex involved in levodopa-induced dyskinesia in 6-hydroxydopamine-lesioned Parkinson's rats.

Authors:  Na Wu; Ying Wan; Lu Song; Chen Qi; Zhenguo Liu; Jing Gan
Journal:  Neuropsychiatr Dis Treat       Date:  2018-07-05       Impact factor: 2.570

Review 10.  Signal transduction in L-DOPA-induced dyskinesia: from receptor sensitization to abnormal gene expression.

Authors:  Giada Spigolon; Gilberto Fisone
Journal:  J Neural Transm (Vienna)       Date:  2018-02-02       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.